Högskolan i Skövde

his.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Ketamine for depression: The role of dissociative effects
University of Skövde, School of Bioscience.
2020 (English)Independent thesis Basic level (degree of Bachelor), 15 credits / 22,5 HE creditsStudent thesis
Abstract [en]

Several trials have reported rapid antidepressant response from the anesthetic drug ketamine although the mechanism behind this effect is not fully understood. Research has focused mainly on ketamine’s action in the brain, including its effects on chemical balance, connections between brain cells and networks, and cognition. Trials with psychedelic drugs have had similar antidepressant results as ketamine, and the quality of the subjective psychedelic experience seems to mediate antidepressant action. Ketamine causes similar alterations of consciousness, which have been viewed as side effects. This thesis examines whether ketamine works in a similar way as psychedelics, where the ketamine-induced dissociative-like experience has a relationship to antidepressant response. Leading theories of depression and ketamine’s action in the brain are presented, and eight studies examining the relationship between ketamine-induced subjective experience and antidepressant response are reviewed. Three included studies found a relationship between psychedelic- and dissociative-like symptoms and reduction in depression, while five did not. The supposed relationship between psychedelic- and dissociative-like symptoms and antidepressant action has not been adequately explored and needs further examination in clinical trials.

Place, publisher, year, edition, pages
2020. , p. 56
Keywords [en]
antidepressant, depression, dissociation, ketamine, major depressive disorder, NMDA receptor antagonist, placebo, psychedelics
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:his:diva-18594OAI: oai:DiVA.org:his-18594DiVA, id: diva2:1445881
Subject / course
Cognitive Neuroscience
Educational program
Cognitive Neuroscience - Applied Positive Psychology
Supervisors
Examiners
Available from: 2020-06-23 Created: 2020-06-23 Last updated: 2025-09-29Bibliographically approved

Open Access in DiVA

fulltext(837 kB)488 downloads
File information
File name FULLTEXT01.pdfFile size 837 kBChecksum SHA-512
e754e19bc3c1411fb29e30c610c5e3d7884fd03e6024f4f469e120895ecd7180f46107277454dbc1fa415d41f0fcfb719116ef043c89d3348557cb00f50c15fb
Type fulltextMimetype application/pdf

By organisation
School of Bioscience
Neurosciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 488 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 1007 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf